mechanisms of gilteritinib resistance in flt3-mutated aml
Published 6 years ago • 468 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
2:15
real-world analysis of gilteritinib for r/r flt3-mutated aml
-
1:33
is gilteritinib the new breakthrough in the treatment of flt3-mutated aml?
-
2:05
phase iii trial of azacitidine and gilteritinib in flt3 mutant aml
-
1:23
the promise of combining venetoclax with gilteritinib for the treatment of flt3-mutated aml
-
2:27
gilteritinib maintenance after allogeneic transplantation in flt3-mutated aml
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
36:58
teg hemostasis analizer system
-
14:21
3mensio ct pre-case planning: valve-in-valve tavr in mosaic
-
3:14
resistance mechanisms to flt3 inhibitors in aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:31
azacitidine and venetoclax plus gilteritinib in the treatment of flt3-mutated aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
4:47
commodore: gilteritinib for the treatment of r/r flt3-mutated aml
-
6:38
gilteritinib plus venetoclax for r/r flt3-mutated aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
0:57
myelosuppression related to gilteritinib treatment in aml & impact on clinical trial design
-
1:52
the management of r/r flt3-mutated aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs